The Third Consensus Conference on the treatment of aplastic anemia

International Journal of Hematology

Volumn 93, Issue 6, 2011, Pages 832-837

  Kojima, Seiji ^a   Nakao, Shinji ^a   Young, Neal ^a   Bacigalupo, Andrea ^a   Gerard, Gerard ^a   Hirano, Naoto ^a   MacIejewski, Jaroslaw ^a   Deeg, Joachim ^a   Marsh, Judith ^a   Zhang, Feng Kui ^a   Lee, Jong Wook ^a   Ozawa, Keiya ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DRUG DOSE REDUCTION; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PATHOGENESIS; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ANEMIA, APLASTIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; STEM CELL TRANSPLANTATION;

EID: 80955177543     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0873-0     Document Type: Conference Paper

References (38)

1. NS Young RT Calado P Scheinberg 2006 Current concepts in the pathophysiology and treatment of aplastic anemia Blood 105 2509 2519
2. NS Young A Bacigalupo JC Marsh 2010 Aplastic anemia: pathopysiology and treatment Biol Blood Marrow Transplant 16 S119 S125
3. C Kahl W Leisenring HJ Deeg TR Chauncey ME Flowers PJ Martin 2005 Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anemia: a long-term follow-up Br J Haematol 130 747 751 (Pubitemid 43906647)
4. Yagasaki H, Takahashi Y, Hama A, Kudo K, Nishio N, Muramatsu H, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant. 2010 Feb 1 [Epub ahead of print].
5. A Bacigalupo G Broccia G Corda W Arcese M Carotenuto A Gallamini 1995 Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party Blood 85 1348 1353
6. S Kojima S Hibi Y Kosaka M Yamamoto M Tsuchida H Mugishima 2000 Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia Blood 96 2049 2054
7. M Führer U Rampf I Baumann A Faldum C Niemeyer G Janka-Schaub 2005 Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival Blood 106 2102 2104 (Pubitemid 41291726)
8. HJ Deeg ID Amylon RE Harris R Collins PG Beatty S Feig 2001 Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation Biol Blood Marrow Transplant 7 208 215 (Pubitemid 32433247)
9. S Kojima T Matsuyama S Kato H Kigasawa R Kobayashi A Kikuta 2002 Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program Blood 100 799 803 (Pubitemid 34832604)
10. S Maury ML Balère-Appert Z Chir JM Boiron C Galambrun K Yakouben 2007 Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient Haematologica 92 589 596 (Pubitemid 350144261)
11. N Hirano MO Butler MS Von Bergwelt-Baildon B Maecker JL Schultze KC O'Connor 2003 Autoantibodies frequently detected in patients with aplastic anemia Blood 102 4567 4575 (Pubitemid 37494126)
12. N Yoshida H Yagasaki Y Takahashi T Yamamoto J Liang Y Wang 2008 Clinical impact of HLA DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anemia Br J Haematol 142 427 435 (Pubitemid 351962169)
13. C Sugimori T Chuhjo X Feng H Yamazaki A Takami M Teramura 2006 Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia Blood 107 1308 1314 (Pubitemid 43242363)
14. JP Maciejewski GJ Mufti 2008 Whole genome scanning as a cytogenetic tool in hematologic malignancies Blood 112 965 974
15. SE Ball FM Gibson S Rizzo JA Tooze JC Marsh EC Gordon-Smith 1998 Progressive telomere shortening in aplastic anemia Blood 91 3582 3592 (Pubitemid 28225723)
16. BP Alter GM Baerlocher SA Savage SJ Chanock BB Weksler JP Willner 2007 Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita Blood 110 1439 1447 (Pubitemid 47443958)
17. PF Fogarty H Yamaguchi A Wiestner GM Baerlocher E Sloand WS Zeng 2003 Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA Lancet 362 1628 1630 (Pubitemid 37443532)
18. H Yamaguchi RT Calado H Ly S Kajigaya GM Baerlocher SJ Chanock 2005 Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia N Engl J Med 352 1413 1424 (Pubitemid 40471449)
19. P Scheinberg JN Cooper EM Sloand CO Wu RT Calado NS Young 2010 Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia JAMA 304 1358 1364
20. P Scheinberg CO Wu O Nunez NS Young 2009 Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia Br J Haematol 144 206 216
21. JR Passweg WS Pérez M Eapen BM Camitta E Gluckman W Hinterberger 2006 Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia Bone Marrow Transplant 37 641 649
22. A Bacigalupo F Locatelli E Lanino J Marsh G Socié S Maury 2005 Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party Bone Marrow Transplant 36 947 950 (Pubitemid 41741556)
23. HJ Deeg M O'Donnell J Tolar R Agarwal RE Harris SA Feig 2006 Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy Blood 108 1485 1491 (Pubitemid 44316112)
24. H Yagasaki S Kojima H Yabe K Kato H Kigasawa H Sakamaki 2009 Tacrolimus/methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis Biol Blood Marrow Transplant 15 1603 1608
25. H Schrezenmeier JR Passweg JC Marsh A Bacigalupo CN Bredeson E Bullorsky 2007 Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia Blood 110 1397 1400 (Pubitemid 47281442)
26. F Locatelli B Bruno M Zecca MT Van-Lint S McCann W Arcese 2000 Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial Blood 96 1690 1697 (Pubitemid 30661050)
27. A Bacigalupo G Socie' E Lanino A Prete F Locatelli A Locasciulli 2010 Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation for alternative donor transplants in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party Haematologica 95 976 982
28. HJ Deeg G Socié G Schoch M Henry-Amar RP Witherspoon A Devergie 1996 Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients Blood 87 386 392 (Pubitemid 26011854)
29. E Di Bona F Rodeghiero B Bruno A Gabbas P Foa A Locasciulli 1999 Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO) Br J Haematol 107 330 334 (Pubitemid 29530219)
30. R Garg S Faderl G Garcia-Manero J Cortes C Koller X Huang 2009 Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome Leukemia 23 1297 1302
31. P Scheinberg SH Fischer L Li O Nunez CO Wu EM Sloand 2007 Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia Blood 109 3219 3224 (Pubitemid 46578057)
32. RA Brodsky AR Chen D Dorr EJ Fuchs CA Huff L Luznik 2010 High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up Blood 115 2136 2141
33. JF Tisdale DE Dunn N Geller M Plante O Nunez CE Dunbar 2000 High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial Lancet 356 1554 1559
34. E Gluckman R Rokicka-Milewska I Hann E Nikiforakis F Tavakoli S Cohen-Scali 2002 Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia Br J Haematol 119 1075 1082 (Pubitemid 35463836)
35. M Teramura A Kimura S Iwase Y Yonemura S Nakao A Urabe 2007 Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan Blood 110 1756 1761 (Pubitemid 47443885)
36. A Tichelli H Schrezenmeier G Socie J Marsh A Bacigalupo U Daehrsen 2009 Use of G-CSF in patients with severe aplastic anemia treatment with ATG and cyclosporine increases neutrophils and decreases infection rates and hospital days but dose not improve long-term outcome: Results of a prospective randomizes clinical trial of the EBMT Blood 114 205a
37. P Armand HT Kim CS Cutler VT Ho J Koreth EP Alyea 2007 Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation Blood 109 4586 4588 (Pubitemid 46743431)
38. Lee JW, Yoon SS, Shen ZX, Ganser A, Hsu HC, Habr D, et al. Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood. 2010 Jun 21 [Epub ahead of print].